InsidersTradesSigma
Follow the Novacyt S.A. stock price and the full insider trade history of the company, a listed issuer based in United Kingdom. Shares trade on the UK market, under the supervision of RNS (LSE). Market capitalisation: €27.1m. The latest transaction was disclosed on 30 March 2026 (Purchase). Among the most active insiders: 1) CEO 2) Chairman 3) NED. The full history is accessible without an account.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
1 of 1 declaration
Novacyt S.A. is a biotechnology company focused on developing diagnostic tests for infectious diseases. It is listed on the London market under the ticker XLON.